Results 171 to 180 of about 35,489 (280)

LukS-PV targeting C5aR inhibits EMT in hepatocellular carcinoma via the BCL6/HDAC6/HSPD1 axis. [PDF]

open access: yesCommun Biol
Ding P   +11 more
europepmc   +1 more source

Supplemental Materials and Methods from Targeting BCL6 in gastrointestinal stromal tumor promotes p53-mediated apoptosis to enhance the antitumor activity of imatinib

open access: gold
Xiangyu Zeng   +12 more
openalex   +1 more source

Acalabrutinib treatment in relapsed/refractory primary cutaneous diffuse large B cell lymphoma, leg type. Case report. [PDF]

open access: yesFront Oncol
Martinez-Gamboa DA   +6 more
europepmc   +1 more source

Correlation of c-MYC, BCL2 and BCL6 proteins overexpression with prognosis in Syrian DLBCL Patients

open access: yesمجلة جامعة دمشق للعلوم الطبية
Background and Aim: c-MYC is a potent transcription factor involved in several cellular processes, and is overexpressed in many cancers, including non-Hodgkin lymphoma (NHL). The most common subtype of NHL is diffuse large B-cell lymphoma (DLBCL). DLBCL
Sulaf Ahmad Farhat Maghrabi   +1 more
doaj  

Engineering Tfh-Specific Nanoadjuvant to Counteract Bile Acid-Induced Mitophagy and Vaccine Hyporesponsivenes. [PDF]

open access: yesTheranostics
Wu H   +11 more
europepmc   +1 more source

The feedback loop of LITAF and BCL6 is involved in regulating apoptosis in B cell non-Hodgkin's-lymphoma

open access: diamond, 2016
Yaoyao Shi   +12 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy